Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
European Journal of Nuclear Medicine and Molecular Imaging|September 3, 2021
Comparison of nodal staging between CT, MRI, and [<sup>18</sup>F]-FDG PET/MRI in patients with newly diagnosed breast cancerJanna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 16, 2010
Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, TanzaniaElmar Saathoff, Michael Pritsch, Christof Geldmacher, et al.Cancers|April 12, 2022
Multiparametric <sup>18</sup>F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerLale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2025
Atezolizumab Monotherapy Window Preceding Combined Neoadjuvant Chemotherapy and Immune Therapy in Triple-Negative Breast Cancer-The neoMono TrialHans-Christian Kolberg, Johannes Schumacher, Ramona Erber, et al.International Journal of Molecular Sciences|April 3, 2021
Adverse Prognostic Impact of the <i>KIT</i> D816V Transcriptional Activity in Advanced Systemic MastocytosisNicole Naumann, Johannes Lübke, Sofie Baumann, et al.Trials|May 17, 2023
PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrantTom Degenhardt, Peter A Fasching, Diana Lüftner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 10, 2024
Impact of <sup>18</sup>F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center TrialKai Jannusch, Lale Umutlu, Julian Kirchner, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2022
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on <sup>18</sup>F-FDG PET/MRI and Machine LearningJanna Morawitz, Benjamin Sigl, Christian Rubbert, et al.International Journal of Molecular Sciences|August 12, 2022
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World SettingRamona Erber, Miriam Angeloni, Robert Stöhr, et al.Clinical Chemistry|January 4, 2024
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical TrialTanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, et al.Pageof 12